ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,617, issued on May 27, was assigned to Topaz Biosciences Inc. (Emeryville, Calif.).
"Cell wall hydrolases targeting c. acnes" was invented by Jennifer Shock (San Francisco), Maritza Miller (Oakland, Calif.), Oliver Liu (San Francisco) and Teresa Shock (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to novel cell wall binding domains, enzymatically active domains, and chimeric cell wall hydrolases with anti-Cutibacterium acnes activity. The disclosure also relates to compositions comprising these, and uses thereof in the treatment of conditions associated with Cutibacterium acnes."
The patent was filed on...